Parolini, Ornella 
; Alviano, Francesco ; Bergwerf, Irene ; Boraschi, Diana ; De Bari, Cosimo ; De Waele, Peter ; Dominici, Massimo ; Evangelista, Marco ; Falk, Werner ; Hennerbichler, Simone ; Hess, David C. ; Lanzoni, Giacomo ; Liu, Bing ; Marongiu, Fabio ; McGuckin, Colin ; Mohr, Stefan ; Nolli, Maria Luisa ; Ofir, Racheli ; Ponsaerts, Peter ; Romagnoli, Luca ; Solomon, Abraham ; Soncini, Maddalena ; Strom, Stephen ; Surbek, Daniel ; Venkatachalam, Sankar ; Wolbank, Susanne ; Zeisberger, Steffen ; Zeitlin, Andy ; Zisch, Andreas ; Borlongan, Cesar V.
; Alviano, Francesco ; Bergwerf, Irene ; Boraschi, Diana ; De Bari, Cosimo ; De Waele, Peter ; Dominici, Massimo ; Evangelista, Marco ; Falk, Werner ; Hennerbichler, Simone ; Hess, David C. ; Lanzoni, Giacomo ; Liu, Bing ; Marongiu, Fabio ; McGuckin, Colin ; Mohr, Stefan ; Nolli, Maria Luisa ; Ofir, Racheli ; Ponsaerts, Peter ; Romagnoli, Luca ; Solomon, Abraham ; Soncini, Maddalena ; Strom, Stephen ; Surbek, Daniel ; Venkatachalam, Sankar ; Wolbank, Susanne ; Zeisberger, Steffen ; Zeitlin, Andy ; Zisch, Andreas ; Borlongan, Cesar V. 
Zusammenfassung
Among the many cell types that may prove useful to regenerative medicine, mounting evidence suggests that human term placenta-derived cells will join the list of significant contributors. In making new cell therapy-based strategies a clinical reality, it is fundamental that no a priori claims are made regarding which cell source is preferable for a particular therapeutic application. Rather, ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric